8
Views
1
CrossRef citations to date
0
Altmetric
Haematology

Increased angiogenesis in the bone marrow of HIV‐positive patients with myelodysplasia

, , , , &
Pages 330-335 | Received 14 Oct 2002, Accepted 18 Mar 2003, Published online: 06 Jul 2009

References

  • Aguayo A, Kantargian H, Talpaz M. Increased angiogenesis in chronic myeloid leukemia and myelodysplastic syndromes (abstract). Blood 1998; 92 (Suppl): 607.
  • Folkman J. Angiogenesis in cancer, vascular rheumatoid and other diseases. Nat Med 1995; 1: 27–31.
  • Irnela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 1997; 78: 672–7.
  • Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperperme-ability and angiogenesis. Am J Pathol 1995; 146: 1029–39.
  • Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637–44.
  • Weidner N, Semple JP, Welch WR, et al. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 1991; 324: 1.
  • Gasparini G, Weidner N, Matula S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer 1993; 55: 738.
  • Srivastava A, Laidler P, Davies RP, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988; 133: 419–23.
  • Bochner BH, Cote RJ, Weidner N, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995; 87: 1603–12.
  • Brouver MK, Deering RE, Brown M, et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994; 73: 678–87.
  • Vamaraki K, Abe S, Tagekawa H, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994; 74: 2245–50.
  • Schnitt Si. The real value of angiogenesis research in breast cancer. Adv Anat Pathol 1997; 4: 23–7.
  • Weidner N, Carroll PR, Flay J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401.
  • Ellis LM, Fidler Ii. Angiogenesis and breast cancer metastasis. Lancet 1995; 346: 388.
  • Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995; 13: 477.
  • Foutanini G, Lucchi M, Viguati S, et al. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: a prospective study. J Natl Cancer lnst 1997; 89: 881.
  • Vacca A, Ribatti D, Roucalli L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503–8.
  • Vacca A, Di Loreto M, Ribatti D, et al. Bone marrow of patients with active Multiple Myeloma angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1 and CD44. Am J Hematol 1995; 50: 9–14.
  • Ribatti D, Vacca A, Nico B, et al. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochem-ical and structural study. Eur J Haematol 1996; 56: 45–53.
  • Rajkumar V, Leong I, Roche P, et al. Prognostic value of bone marrow angiogenesis on multiple myeloma. Clin Cancer Res 2000; (6): 3111–6.
  • Kini AR, Kay NE, Peterson LA. Increased bone marrow angio-genesis in B-cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414–8.
  • Kay N, Jelinek D, Peterson LA. Angiogenesis in B-chronic lym-phocytic leukemia. Leukemia Res 2001; 25: 485–6.
  • Vacca A, Ribatti D, Presta M, et al. Bone marrow neovasculatization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064–73.
  • Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815–21.
  • Hussong JW, Rodgers GM, Shami Pi. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–13.
  • Mesa R, Hanson C, Rajkumar V, et al. Evaluation and clinical correlations of bone marrow angiogenis in myelofibrosis with myeloid metaplasia. Blood 2000; 96: 10.
  • De Bont E, Rosati S, Jacobs S, et al. Increased bone marrow vascularization in patients with acute myeloid leukemia-a possible role for vascular endothelial growth factor. Br J Haematol 2001; 113: 296–304.
  • Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–5.
  • Pruneri G, Bertolini F, Soligo D, et al. Angiogenesis in myelodys-plastic syndromes. Br J Cancer 1999; 81:8 1398–1401.
  • Korkolopoulou P, Apostolidou E, Pavlopoulos P, et al. Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia 2001; 15: 1369–76.
  • Clatch R, Krigman H, Peters M, et al. Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia. Br J Haematol 1994; 88: 685–92.
  • Thiele J, Zirbes T, Wiemers P, et al. Incidence of apoptosis in HIV-myelopathy, myelodysplastic syndromes and non-specific inflam-matory lesions of the bone marrow. Histopathology 1997; 30: 307–11.
  • Karcher D, Frost A. The bone marrow in human immunodeficiency virus (HIV)-related diseases. Morphology and clinical correlation. Am J Clin Pathol 1991; 95: 63–71.
  • Thiele J, Zirbes T, Bertsch HP, et al. AIDS-related bone marrow lesions-myelodysplastic features or predominant inflammatory reac-tive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Anal Cell Pathol 1996; 11: 141–57.
  • Katsarou O, Terpos E, Patsouris E, et al. Myelodysplastic features in patients with long-term HIV infection and hemophilia. Hemophilia 2001; 7: 47–52.
  • Centers for Disease Control, US Department of Health and Human Services Classification system for human T-lymphotropic virus infec-tions. Ann Intern Med 1986; 105: 234–7.
  • Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
  • Shi SR, Key ME, Kalra K. Antigen retrieval in formalin-fixed, paraffin embedded tissues, an enhancement method for immunohisto-chemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741–8.
  • Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80.
  • Hansen S, Grabau DA, Rose C, et al. Angiogensis in breast cancer: a comparative study of the observer variability of methods for deter-mining microvessel density. Lab Invest 1998; 78: 1563–73.
  • Bruyn PPH, Breen PC, Thomas TB. The microcirculation of the bone marrow. Anat Rec 1970; 168: 55–68.
  • Branemark PI. Bone marrow microvascular structure and function. Adv Microcirc 1968; 1: 1–65.
  • Yamaguchi H, Ishii E, Saito S, et al. Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol 1996; 94: 606–11.
  • Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–5.
  • Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, et al. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995; 108: 231–41.
  • Vermeulen P, Verhoeven D, Fierens H, et al. Microvessel quantifica-tion in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 1995; 71: 340–3.
  • Bellamy W, Richter L, Frutiger Y, et al. Vascular endothelial cell growth factor (VEGF) is an autocrine promoter of ALIP and leukemia progenitor formation in myelodysplastic syndromes (MDS). Blood 1999; 94 (Suppl 1): 389e (Abstr).
  • Schneider D, Picker L. Myelodysplasia in the acquired immune deficiency syndrome. Am J Clin Pathol 1985; 84: 144–52.
  • Spivak J, Bender B, Quinn T. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984; 77: 224–8.
  • Scadden D, Zeira M, Woon A, et al. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990; 76 (2): 317–22.
  • Moses A, Williams S, Heneveld M, et al. Human immunodeficiency virus infection of bone marrow endothelial reduces induction of stromal hematopoietic growth factors. Blood 1996; 87 (3): 919–25.
  • Zauli G, Furlini G, Vitale M, et al. A subset of human CD34± hematopoietic progenitors express low levels of CD34, the high affinity receptor for human immunodeficiency virus type 1. Blood 1995; 84(6): 1896–905.
  • Chi D, Henry J, Kelly J, et al. The effects of HIV infection on endo-thelial function. Endothelium 2000; 7 (4): 223–42.
  • Hymes K, Karpatkin S. Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 1997; 34 (2): 117–25.
  • Collins T, Read M, Neish A, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-Kappa B and cytokine-inducible enhancers. FASEB J 1995; 9: 899–909.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.